News: Chimerix Inc (CMRX.OQ)

CMRX.OQ on NASDAQ Stock Exchange Global Market

36.80USD
24 Dec 2014
Price Change (% chg)

$0.70 (+1.94%)
Prev Close
$36.10
Open
$36.10
Day's High
$37.95
Day's Low
$36.10
Volume
62,345
Avg. Vol
284,815
52-wk High
$41.29
52-wk Low
$14.02

Search Stocks
Select another date:

Thu, Nov 13 2014

Chimerix antiviral to be tested in West African Ebola trial

- Chimerix Inc said its experimental broad-spectrum antiviral was one of two agents to be tested in a trial in confirmed Ebola patients in West Africa.

Chimerix antiviral to be tested in West African Ebola trial

Nov 13 - Chimerix Inc said its experimental broad-spectrum antiviral was one of two agents to be tested in a trial in confirmed Ebola patients in West Africa.

Chimerix drug used for Ebola shows promise in respiratory cases

- Chimerix Inc said its experimental oral antiviral, which was used earlier this week to treat the first Ebola patient diagnosed in the United States, improved the survival rate of patients with a certain type of respiratory infection.

UPDATE 1-Chimerix drug used for Ebola shows promise in respiratory cases

Oct 8 - Chimerix Inc said its experimental oral antiviral, which was used earlier this week to treat the first Ebola patient diagnosed in the United States, improved the survival rate of patients with a certain type of respiratory infection.

US STOCKS-Chimerix, Symantec rise in early trading

* Futures up: Dow 29 pts, S&P 5 pts, Nasdaq 7 pts (Adds Chimerix, Symantec)

Chimerix antiviral drug shows potential in late-stage study

Oct 8 - Chimerix Inc said its experimental oral antiviral improved the survival rate of patients with a certain type of respiratory infection, according to preliminary data from a late-stage study.

Nebraska hospital says treating its Ebola patient with Chimerix drug

- A Nebraska hospital treating U.S. patient Ashoka Mukpo for the deadly Ebola virus said on Tuesday it was using the experimental drug brincidofovir from Chimerix Inc.

Nebraska hospital says treating its Ebola patient with Chimerix drug

Oct 7 - A Nebraska hospital treating U.S. patient Ashoka Mukpo for the deadly Ebola virus said on Tuesday it was using the experimental drug brincidofovir from Chimerix Inc .

U.S. Ebola patient receives experimental drug from Chimerix

- After nearly a week in hospital, the first Ebola patient diagnosed in the United States began to receive an experimental therapy initially developed to treat other viral diseases, according to the Dallas hospital where he lies in critical condition.

UPDATE 2-U.S. Ebola patient receives experimental drug from Chimerix

(Rewrites throughout with details on patient receiving drug and how it works)

Select another date:

Press Releases

Search Stocks